With increasing time since diagnosis, only the severe infections continued to cause symptoms.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) A federal advisory committee yesterday endorsed FluMist, the nasal-spray form of seasonal influenza vaccine, as a good option for children aged 2 through 4 years.
(CIDRAP News) – The White House recently issued a lengthy homeland security directive aimed at bolstering the response of federal, state, and local public health systems to national emergencies such as bioterrorist attacks, influenza pandemics, and natural disasters.
(CIDRAP News) – Scientists investigating why seasons drive annual influenza epidemics have charted how low humidity and cold temperatures contribute to the spread of the disease in laboratory animals.
The research group, from Mt Sinai School of Medicine in New York City, published their findings yesterday in the October issue of Public Library of Science Pathogens (PLoS Pathogens).
(CIDRAP News) The World Health Organization (WHO) yesterday released a report on patenting issues related to influenza viruses, following up on a resolution adopted by the World Health Assembly in May to address the concerns of Indonesia and other developing countries about access to pandemic flu vaccines and treatments.
(CIDRAP News) The US government's pandemic influenza preparedness plans need to pay more attention to children, especially their need for antiviral drugs and the effects of prolonged school closings, according to a report released today by public health and pediatrics experts.
(CIDRAP News) An Institute of Medicine (IOM) committee that studied issues concerning personal protective equipment (PPE) for healthcare workers in an influenza pandemic is calling for renewed efforts to learn how influenza viruses spread, promote proper use of PPE, and improve the equipment itself.
(CIDRAP News) Public health officials looking for ideas and tools to help them prepare for an influenza pandemic can find an online collection of peer-reviewed resources on a Web site that was officially launched today: PandemicPractices.org.
(CIDRAP News) BioCryst Pharmaceuticals, Inc, yesterday announced disappointing early results in a phase 2 study of its antiviral drug peramivir, which is seen as a potential new weapon against influenza.
(CIDRAP News) Three years ago President Bush directed the Department of Homeland Security (DHS) to consolidate biosurveillance data to improve the nation's ability to detect bioterrorism and other infectious disease threats, but federal auditors warned this week that leadership problems have seriously hampered the program.
